To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Speech in Lords Chamber - Mon 12 Feb 2024
Royal Navy: Aircraft Carriers

Speech Link

View all Baroness Northover (LD - Life peer) contributions to the debate on: Royal Navy: Aircraft Carriers
Division Vote (Lords)
6 Feb 2024 - Electoral Commission Strategy and Policy Statement - View Vote Context
Baroness Northover (LD) voted Aye - in line with the party majority and in line with the House
One of 57 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes
Vote Tally: Ayes - 175 Noes - 159
Division Vote (Lords)
6 Feb 2024 - Automated Vehicles Bill [HL] - View Vote Context
Baroness Northover (LD) voted Aye - in line with the party majority and against the House
One of 63 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes
Vote Tally: Ayes - 200 Noes - 204
Written Question
Contraceptives: Taxation
Thursday 1st February 2024

Asked by: Baroness Northover (Liberal Democrat - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to their policy paper 2024 voluntary scheme for branded medicines pricing, access and growth: summary of the heads of agreement, published on 20 November 2023, what assessment they have made of any potential detrimental impact on women's health if the tax on the contraceptive implant Nexplanon is increased to 35 per cent.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG) introduces a new way of controlling the cost of older medicines that is explicitly pro-innovation and pro-competition. We do not anticipate this resulting in a detrimental impact on women's health or, given the available mitigations, on the supply of medicines.

Medicines for women’s health will be subject to the VPAG in the same way that all other medicines are. They will be subject to the top up payment percentage only when they have not seen a sufficient price decline since the active substance lost market exclusivity.

In exceptional circumstances, where a product would otherwise be uneconomic to supply, companies can apply to the Department for a price increase or for an adjustment to the top up payment percentage that applies.

Speech in Lords Chamber - Mon 29 Jan 2024
Safety of Rwanda (Asylum and Immigration) Bill

Speech Link

View all Baroness Northover (LD - Life peer) contributions to the debate on: Safety of Rwanda (Asylum and Immigration) Bill
Division Vote (Lords)
29 Jan 2024 - Safety of Rwanda (Asylum and Immigration) Bill - View Vote Context
Baroness Northover (LD) voted Aye - in line with the party majority and against the House
One of 67 Liberal Democrat Aye votes vs 1 Liberal Democrat No votes
Vote Tally: Ayes - 84 Noes - 206
Division Vote (Lords)
23 Jan 2024 - Investigatory Powers (Amendment) Bill [HL] - View Vote Context
Baroness Northover (LD) voted Aye - in line with the party majority and against the House
One of 61 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes
Vote Tally: Ayes - 201 Noes - 227
Division Vote (Lords)
22 Jan 2024 - Asylum: UK-Rwanda Agreement - View Vote Context
Baroness Northover (LD) voted Aye - in line with the party majority and in line with the House
One of 65 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes
Vote Tally: Ayes - 214 Noes - 171
Scheduled Event - Thursday 11th January
View Source
Lords - Debate - Main Chamber
UK’s contribution to international development, particularly in relation to the impact of climate change on developing nations
MP: Baroness Northover
Speech in Lords Chamber - Thu 11 Jan 2024
Climate Change: Impact on Developing Nations

Speech Link

View all Baroness Northover (LD - Life peer) contributions to the debate on: Climate Change: Impact on Developing Nations